Company News

Brenntag Specialties Inks Distribution Contract with BiCT

Agreement will distribute active ingredient Lactive for the beauty and personal care industries in Iberia and Italy.

Author Image

By: Lianna Albrizio

Associate Editor

Brenntag Specialties has inked a distribution agreement with BiCT, a leading European biotechnology company.

The collaboration introduces Lactive – an award-winning skincare ingredient that is a sustainable and effective alternative to synthetic formulations – to the beauty and personal care industries in Iberia and Italy.

Lactive is the bioactivated form of lactoferrin, a natural milk protein with antimicrobial, anti-inflammatory and wound-healing properties. Per company officials, it helps to rebalance the skin’s microbiome and is therefore ideal for acne-prone skin. It strengthens the skin barrier for skin prone to atopic dermatitis and prevents skin-aging by promoting regeneration and resilience.

“Lactive stands as a game-changing bioactive ingredient, empowering brands to create skincare solutions,” said Silvia Rapacioli, general manager at BiCT. “With BiCT’s new collaboration with Brenntag, this innovation will reach even more markets, enabling tailored formulations and expert-driven solutions that set brands apart in the competitive beauty industry.”

Keep Up With Our Content. Subscribe To Happi Newsletters